Liv Hospital and Istinye University Announce Groundbreaking Academic Collaboration with University of Pennsylvania's Perelman School of Medicine
ISTANBUL, May 26, 2025 (GLOBE NEWSWIRE) -- Liv Hospital and Istinye University have signed a comprehensive collaboration protocol with the University of Pennsylvania's Perelman School of Medicine to advance cutting-edge treatments, scientific research, and education programs. The agreement highlights innovative approaches such as CAR T-cell therapy and proton therapy, and paves the way for new horizons in healthcare—spanning clinical practices, second-opinion services, international training initiatives, and the establishment of state-of-the-art cell production laboratories.Pioneering New Frontiers in Medicine
Under this collaboration, Liv Hospital and Istinye University will develop joint clinical programs focusing on advanced treatment methods—particularly CAR T-cell therapy and proton therapy—and facilitate broader patient access to these breakthrough treatments. Turkish healthcare professionals will benefit from scientific conferences featuring Perelman School of Medicine experts, while tailored training programs—both online and in person—will be offered to Liv Hospital and Istinye University physicians.
Second-Opinion Service for Global Assurance
For complex and advanced cases, Perelman School of Medicine experts will provide consultation and assessments to physicians at Liv Hospital and Istinye University, ensuring patients benefit from a global standard of care. This second-opinion program will give healthcare professionals a direct line to internationally renowned specialists, fostering collaborative insights and a broader perspective on diagnostic and treatment strategies.
Strengthening Research Through Collaboration
Beyond clinical applications and education, the partnership sets a robust framework for joint biomedical research. All projects will adhere to international scientific and ethical guidelines, driving knowledge creation, innovation, and progress toward the treatments of the future.
A New Era in Cancer Care: Cell-Based Therapies
According to Prof. Dr. Erdal Karaöz, Director of the Liv Hospital Regenerative Medicine and Stem Cell Center,
'Today, cellular therapy has become a centerpiece of groundbreaking cancer treatments. Our collaboration with the University of Pennsylvania—the birthplace of many revolutionary scientific developments in this field—is immensely significant. Liv Hospital will be among the first institutions in Turkey to implement cellular therapies, and through the international-standard laboratories we are establishing with Istinye University, we are preparing to produce these therapeutic cells in-house.
'Under the supervision of the Ministry of Health and in compliance with all scientific and ethical regulations, these laboratories will produce cell-based treatment products that will soon be used in Turkey—especially for certain hematologic cancers. This approach is not limited to oncology; it has the potential to evolve into a transformative treatment model for solid tumors and for ongoing clinical research in autoimmune disorders. In the future, diseases like type 1 diabetes, systemic lupus erythematosus, and multiple sclerosis (MS) may also be treated using this technology.'
New Hope for Resistant Cancers: CAR T-Cell Therapy
'Harnessing the power of cellular therapies—particularly CAR T-cell therapy—offers renewed hope for patients with lymphoma, specific subtypes of leukemia, and multiple myeloma that are resistant to current treatments or have relapsed,' said Prof. Dr. Mehmet Hilmi Doğu, Hematology Specialist at Liv Hospital. 'We are working diligently to provide this advanced technology—often inaccessible in many parts of the world in collaboration with internationally recognized centers in this field.
'Moreover, CAR T-cell therapy extends beyond hematologic malignancies. It shows promise for autoimmune conditions and certain neurological disorders, and we believe it will soon become an indispensable pillar of modern medicine.'
Strengthening a Global Vision
Liv Hospital Group Coordinator and Istinye University Executive Board Member, Meri İstiroti, expressed enthusiasm about the partnership: 'We view scientific collaborations as more than just knowledge-sharing; they are transformative engagements that directly shape the future of healthcare. At Liv Hospital and Istinye University, we strive for a vision that not only addresses today's needs but anticipates tomorrow's challenges. Partnering with an institution as established and forward-thinking as the Perelman School of Medicine at the University of Pennsylvania will fortify our country's international standing in healthcare.
'This collaboration—encompassing clinical programs that increase access to advanced treatment methods and research projects that drive scientific innovation—aims to add value across all levels of healthcare. We believe it will offer inspiring opportunities for patients, students, and budding researchers, further enhancing our collective capacity to deliver world-class care.'
About Liv Hospital
Founded in 2013 in Istanbul, Türkiye, Liv Hospital (an abbreviation of 'Leading International Vision') is a premier healthcare network offering world-class, multidisciplinary medical services. As part of MLP Care, one of Türkiye's largest healthcare providers, Liv Hospital operates JCI-accredited facilities in Istanbul (Ulus and Vadistanbul), Ankara, Samsun, Gaziantep, and an international branch in Baku, Azerbaijan.
Renowned for combining advanced medical technologies with personalized, patient-centered care, Liv Hospital provides comprehensive treatment across more than 50 specialties. It is especially distinguished in fields such as oncology, cardiovascular surgery, organ transplantation, robotic surgery, and regenerative medicine.
With a strong focus on international health tourism, Liv Hospital welcomes thousands of patients from over 80 countries each year. Its multilingual International Patient Center delivers full-service assistance, including medical second opinions, treatment coordination, visa and travel arrangements, interpreting services, and post-treatment follow-up—ensuring a seamless experience from arrival through recovery.
Liv Hospital is committed to clinical excellence, continuous innovation, and compassionate care, making it one of the most trusted healthcare destinations in the region.
Website: https://www.livhospital.com/en
Media Contact:FL PR and Communicationsasset@flcommunications.co.uk+905330202554
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6b98f9d2-0ccf-4ba7-8b34-5cf7764fa53a
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Weight-loss jabs may need to be taken for life, experts warn
Weight-loss jabs may have to be used for many years if the long-term benefits to patients and the NHS are to be realised, experts have said. The drugs are sold under brand names like Mounjaro and Wegovy and work by reducing food cravings. Obese patients can currently be prescribed the jabs on the NHS after being referred to specialist weight loss clinics, which are usually located in hospitals. Hundreds of thousands of people also access the medication privately at pharmacies. There have been warnings about buying potentially unsafe jabs online from unregulated retailers and potentially missing out on wraparound support. Experts said the jabs should not be seen as the first option in weight loss and should be used in conjunction with lifestyle changes, such as eating more healthily and increasing exercise. Professor Graham Easton, a GP who has been using weight loss jabs himself, said: 'I think it's a major issue about the proper funding and resourcing of not only the GPs in the surgeries but also the wraparound care we talked about. 'I think the other issue is that so far, to my knowledge, the NHS and National Institute for Health and Care Excellence have talked about this being something you take for two years, and that's probably related to data from research studies. 'But as we discussed, this is likely to be a lifelong commitment if it is going to be worthwhile to the NHS. 'There's no point in most people taking it for a couple of years and then have the weight bouncing back. 'You can argue possibly you're about to prepare for surgery or something, but in most cases it doesn't make any sense. 'Then I think there's a big issue around access. Most obesity occurs in poorer populations as wealthier populations tend to not be so affected. 'There's a massive sort of socio-economic inequality and there is a worry about this driving that inequality even further. 'Unless the NHS makes sure that these are available across the board equally, I think that's a major risk.' Prof Easton said recent studies had shown people who stopped taking the drugs had put the weight they lost back on within around a year. 'That's often true of any diet, people would say, and that's certainly my experience of having wrestled with my weight in diets over the years,' he said. 'All I would say that I found interesting from that review was that they were suggesting perhaps that weight returns even quicker after having been on GLP-1 drugs. 'Then speculating, because there was no way of knowing from that review, that perhaps it's because people are not changing the behaviours we've been talking about like exercise and other lifestyle changes, just relying on the drugs. 'When you stop them, of course, you're going to put weight back on. The switch is turned back off, or whatever it was. 'I mean very similar to, for example, statins or anti-hypertensive blood pressure medications, if you want lifelong effects, you have to keep on them lifelong.' Prof Easton was speaking at an event at the Cheltenham Science Festival discussing the growing use of weight loss drugs with neurophysiologist Dr Simon Cork and consultant endocrinologist and obesity expert Dr Tony Goldstone. Dr Cork said the jabs have an important role to play in losing weight but are part of wider changes to diet and lifestyle. 'I think we have to understand that diet is always limited. People will tend to lose on average around 5% of their body weight on a diet,' he said. 'But you're hungry, you're miserable, you're tired, your wife hates you because you're so grumpy, you're not going to continue with that. 'But we should absolutely all be looking at our diet and all changing our diet, and doing something.' Dr Goldstone said weight loss drugs had been used in the treatment of diabetes for over a decade and had benefits of reducing the risk of developing other conditions. 'We're now in the third and fourth generation of these drugs, but the first generation of these drugs we've been using for 15 years for diabetes,' he said. 'There is nothing of concern that has emerged. In fact, all we're seeing are benefits. I'm not too worried about longer term side effects coming out. 'There is no real biological reason why there should be dangerous side-effects in the way that we know these drugs work. 'The benefits of the weight loss improvement in the diabetes are actually by themselves helping health and preventing other diseases, like cancer, heart attacks, renal failure, and potentially even reducing the risk of Alzheimer's disease. 'All those benefits, even if there was something that we hadn't really thought of that emerged down the line, I suspect that the harm of that is outweighed by the potential benefits of weight loss improvement in diabetes control.' Dr Cork said no drug is without side-effects and previous weight loss medications had failed because of them. 'There are side-effects, there are some concerning side-effects that tend to be very rare, but then you can monitor for those side-effects,' he said. 'As long as you're getting the correct care, as long as your GP is aware that you're taking them, then those should be identified. 'If you do find those side-effects, you can stop taking the drug.'
Yahoo
3 hours ago
- Yahoo
UK firm achieves tritium breakthrough, could boost nuclear fusion fuel supply
Astral Systems, a UK-based private commercial fusion company, has claimed to have become the first firm to successfully breed tritium, a vital fusion fuel, using its own operational fusion reactor. This achievement, made with the University of Bristol, addresses a significant hurdle in the development of fusion energy. The milestone came during a 55-hour Deuterium-Deuterium (DD) fusion irradiation campaign conducted in March. Scientists from Astral Systems and the University of Bristol produced and detected tritium in real-time from an experimental lithium breeder blanket within Astral's multi-state fusion reactors. "There's a global race to find new ways to develop more tritium than what exists in today's world – a huge barrier is bringing fusion energy to reality," said Talmon Firestone, CEO and co-founder of Astral Systems. "This collaboration with the University of Bristol marks a leap forward in the search for viable, greater-than-replacement tritium breeding technologies. Using our multi-state fusion technology, we are the first private fusion company to use our reactors as a neutron source to produce fusion fuel." Astral Systems' approach uses its Multi-State Fusion (MSF) technology. The company states this will commercialize fusion power with better performance, efficiency, and lower costs than traditional reactors. Their reactor design, the result of 25 years of engineering and over 15 years of runtime, incorporates recent understandings of stellar physics. A core innovation is lattice confinement fusion (LCF), a concept first discovered by NASA in 2020. This allows Astral's reactor to achieve solid-state fuel densities 400 million times higher than those in plasma. The company's reactors are designed to induce two distinct fusion reactions simultaneously from a single power input, with fusion occurring in both plasma and a solid-state lattice. The reactor core also features an electron-screened environment. This design reduces the energy needed to overcome the Coulomb barrier between particles, which lowers required fusion temperatures by several million degrees and allows for higher performance in a compact size. The ability to generate tritium within the reactor is crucial. A sustainable fusion energy system needs to produce more fuel than it consumes. This development shows a path toward solving that engineering challenge. In this regard, the latest breakthrough has broad and major implications for several industries, including nuclear fusion energy. 'As we progress the fusion rate of our technology, aiming to exceed 10 trillion DT fusions per second per system, we unlock a wide range of applications and capabilities, such as large-scale medical isotope production, fusion neutron materials damage testing, transmutation of existing nuclear waste stores, space applications, hybrid fusion-fission power systems, and beyond,' remarked the company. Professor Tom Scott, who led the University of Bristol's team, supported by the Royal Academy of Engineering and UK Atomic Energy Authority, concluded, "We're now pushing to quickly optimise our system to further enhance our tritium breeding capability." 'This landmark moment clearly demonstrates a potential path to scalable tritium production in the future and the capability of Multi-State Fusion to produce isotopes in general.'
Yahoo
3 hours ago
- Yahoo
'Troubling decline' in secondary school PE lessons
A "troubling decline" in the number of hours England's secondary school pupils spend doing physical education (PE) "should be a wake-up call to society", according to children's exercise charity the Youth Sport Trust (YST). The organisation says figures show "nearly 4,000 PE hours lost in the last year alone" in state-funded schools, and calls for "urgent action to protect and prioritise" the subject. The YST also claims that since the London 2012 Olympics "almost 45,000 PE hours have disappeared from secondary school timetables", and that the number of PE teachers in England has also dropped by 7%. In response, the government said it is "determined to break down barriers to accessing PE and school sports for young people". In its annual report, the YST says that 2.2 million children in England are now doing less than 30 minutes of activity a day, and less than half (48%) are meeting the UK's Chief Medical Officers' recommendation of at least 60 minutes of physical activity a day. It says the steepest decline has hit 11-14-year-olds, with more than 2,800 hours cut and 347 teachers lost for this age group in the past year, at a time of rising childhood obesity rates. YST also adds that girls, children with special educational needs and disabilities (SEND), and those from disadvantaged backgrounds "continue to face the greatest barriers to being active". However, the study also found that 93% of young people believe PE is important, 71% want to be more active at school, and 96% of teachers agree that sport and play benefit mental wellbeing. While PE is a mandatory subject in schools, the recommended amount of two hours a week is not enforced. YST chief executive Ali Oliver said: "Our children are moving less, feeling unhappier, and losing access to the transformative power of PE, contributing to stagnant physical activity levels. "The fall in PE hours is sadly an exacerbation of a longer-term trend and should be a wake-up call to society, from policymakers to schools and parents. "Unless we take action to reverse these damaging trends and increase activity levels to improve wellbeing, we risk failing a generation." In a statement, the government said: "These figures highlight the government's dire inheritance, but we're determined to break down barriers to accessing PE and school sports for young people through our Plan for Change, helping to improve their mental and physical wellbeing. "We are working across the government and with our partners including Youth Sport Trust and Sport England to boost participation and have already invested £100m to upgrade sports facilities and launched a programme to improve access to sports for pupils with special education needs and disabilities. "Our ongoing curriculum and assessment review seeks to deliver a broader curriculum, so that children do not miss out on subjects including PE and sport."
